HEPATITIS IN PATIENTS TREATED BYHEMODIALYSIS

During the last decades, according the international registers (in 2011–2013) there is a steady increase of amount of patients with terminal kidney insufficiency. For the aim of continuation a life to such patients we apply the methods of renal replacement therapy, one of each is hemodialysis. The risk of infecting ofparenterally hepatitis viruses grows in connection with the features ofprocedure of hemodialysis, first of all hepatitis B and С. Persisting in an organism, these viruses can become reason of development of chronic disease of liver, with development of cirrhosis or and hepatocellular carcinoma. World experience shows that frequency infecting hepatitis In (HBV) and С (HCV) in terms by treatment of hemodialysis (HD), high and depends, first of all, from intensity of epidemic process in a region, and also from the level of socio–economic development of country. In this work we analysed prevalence of infecting hepatitis B and С in the different countries of the world, and also outlined basic recommendations in relation on timely diagnostics and warning of infection of hepatitis of patients who treated by hemodialysis.